GE Healthcare and Indi Molecular to collaborate on diagnostic tool for clinical management of immunotherapy patients

Chalfont St Giles, UK & Culver City, CA, May 14 2019 – GE Healthcare and Indi Molecular, Inc, a  California-based biotechnology company, have announced plans to develop immune cell-targeted Positron-Emission Tomography (PET) tracer candidates, based on Indi Molecular’s proprietary Protein Catalyzed Capture (PCC) technology. These tracer candidates, if successful, could help identify molecular markers of cytotoxic T-cells,... Read more

New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world’s leading cause of infectious disease deaths

Basel, 14 May 2019 New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world’s leading cause of infectious disease deaths New tests on cobas 6800/8800 systems provide clinicians information to help speed treatment and reduce the spread of infection Rising challenge of drug resistance compounds the tuberculosis... Read more

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 14 May 2019 Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. Parties elect to refile Premerger Notification and Report Forms on or about 23 May 2019 to provide the government with additional... Read more

Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications

World’s highest field preclinical MRI will be used for oncology and neuroscience research MONTREAL, May 13, 2019 /PRNewswire/ — At the Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM), Bruker today announced an agreement to develop the world’s first 18 Tesla 11 cm bore, preclinical ultra-high field (UHF) magnetic resonance imaging... Read more

Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 10 May 2019 Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting Study results across 17 medicines reflect our commitment to personalised care with advances in targeted therapies, immunotherapy, and diagnostics, data and analytics New pivotal data on fixed-duration combination of Venclexta/Venclyxto... Read more

Two Pore Guys Rebranded as Ontera Under New Leadership to Bring NextGeneration Molecular Diagnostics to the Field and Point of Use

Murielle Thinard-McLane Appointed New CEO Santa Cruz, Calif. — May 9, 2019 — Two Pore Guys, Inc., the leader in silicon-based nanopore diagnostics, has rebranded as Ontera Inc. to reflect its broader mission of providing better biological information for a healthier planet. As part of these changes, the company has appointed two seasoned executives to... Read more

Greiner Bio-One Launches New MiniCollect® K2EDTA Capillary Tube into the Healthcare Market

07. May 2019 Greiner Bio-One is pleased to announce the launch of the newly redesigned MiniCollect® K2EDTA Capillary Collection Tube. These tubes are intended for the collection, transport and evaluation of capillary samples. The redesigned product includes an integrated scoop, allowing droplets of blood to be collected easily following skin puncture and reducing the number... Read more

Agilent Announces Unique Portfolio to Advance Immunotherapy

Agilent Announces Unique Portfolio to Advance Immunotherapy Innovative solution provides cell-based tools for translational research and development SANTA CLARA, Calif., May 7, 2019 Agilent Technologies Inc. (NYSE: A) announces a unified portfolio of products for immunotherapy researchers. The innovative solution will showcase at Immunology 2019, the 103rd Annual Meeting of the American Association of Immunologists... Read more

New Study Results Find That The Blood Biomarker MR-proADM May Prevent Early Hospital Discharge in Patients with Developing Sepsis

New Study Results Find That The Blood Biomarker MR-proADM May Prevent Early Hospital Discharge in Patients with Developing Sepsis Multi-centre analysis shows that incorporation of MR-proADM (mid-regional proadrenomedullin) into an early management of patients with suspected infection protocol may aid rapid clinical decision making in the emergency department HENNIGSDORF, Germany, May 2, 2019 /PRNewswire/ —... Read more

Beckman Coulter Expands Portfolio of Standardized ClearLLab IVD Reagents for the Clinical Flow Cytometry Lab

New 10-Color System with Kaluza C Software Streamlines Workflow and QC Reporting for Flow Cytometric Leukemia & Lymphoma* Analysis  Miami, USA (April 24, 2019) ─ Beckman Coulter is launching the ClearLLab 10C System for the clinical flow cytometry lab.  The new system is the first 10-color IVD panel of immunophenotyping reagents cleared by the Food and... Read more